Synthetic biology and precision medicine in blood and gynaecological cancers
Dr Stadler presents results at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting that show people whose tumours have high micro satellite instability (MSI-H) are more likely to have the hereditary condition Lynch syndrome.
She describes how inherited mutations in Lynch syndrome-associated genes were found in 16% of people with MSI-H tumors, compared to 1.9% of those with MSI-I tumors and only 0.3% of those with MSS tumors.
For more on these results, watch her interview with ecancer and read our news coverage here.
Synthetic biology and precision medicine in blood and gynaecological cancers
KEYNOTE-756 trial shows increased response in ER+/HER2- breast cancer
Feasibility and safety of boost at 74 Gy based on interim FDG-PET during thoracic radio-chemotherapy for NSCLC patients
Adjuvant radiotherapy has no benefit following radical prostatectomy
Neoadjuvant cemiplimab shows favourable event-free, disease-free and overall survival rates in patients with resectable CSCC
Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC
OncoAlert Round Up for September 15-21, 2023
The 5-year long-term outcomes of radiation technique for locally advanced NSCLC
The Southeast Asian Breast Cancer Symposium; background, aims and successes